Corporate insider
Tenjarla Srini
SVP, CMC & FormulationCIK 0002029985
Disclosed transactions2
Buys / sells0 / 0
Max Insider Score19
Connections with evidence1
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 15 | Tenjarla SriniSVP, CMC & Formulation |  SERSerina Therapeutics, Inc.Grant or award | A | — 85.6K sh | May 26, 2026 traded May 21, 2026 | |
Verified connections
- Insider ofevidenceSerina Therapeutics, Inc.SVP, CMC & Formulation · Feb 17, 2026